N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion

References

• Gu H, Rao S, Zhao J, et al. Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. J Cancer Res Clin Oncol 2009;135:1777–82
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang X, Ayman WY, et al. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv 2013;20:86–93
   PubMed Web of Science ®Google Scholar
• Wang XP, Lv HX, Waddad AY, et al. Studies on intestinal absorption kinetics of gambogic acid by rat single pass perfusion in situ. China J Chin Materia Medica 2012;37:2079–83
   Google Scholar
• Yi T, Yi Z, Cho SG, et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 2008;68:1843–50
   PubMed Web of Science ®Google Scholar
• Guo QL, Zhao L, Wu ZQ, et al. Eefect of gambogic acid on the hemopoietic and immune functions in experimental animals. Chin J Nat Med 2003;4:229–32
   Google Scholar
• Qu G, Zhu X, Zhang C, Ping Q. Modified chitosan derivative micelle system for natural anti-tumor product gambogic acid delivery. Drug Deliv 2009;16:363–70
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Inter J Nanomed 2012;7:713–21
   PubMed Web of Science ®Google Scholar
• Wang CL, Zhang HJ, Chen BA, et al. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles. Inter J Nanomed 2011;6:1929–35
   PubMed Web of Science ®Google Scholar
• Cao J, Sun J, Wang X. N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm 2009;35:1339–47
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Soares AF, et al. Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles. Drug Dev Ind Pharm 2012;38:1441–50
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhang C, Wu X, et al. Preparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivatives. Drug Dev Ind Pharm 2008;34:2–9
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Bae Y, Miyata K, et al. Smart polymeric micelles for gene and drug delivery. Drug Discov Today Technol 2005;2:21–6
   PubMedGoogle Scholar
• Nishiyama N, Kataoka K. Nanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug function. Adv Polym Sci 2006;193:67–101
   Web of Science ®Google Scholar
• Merzlikine A, Rotter C, Rago B, et al. Effect of chitosan glutamate, arbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats. Drug Dev Ind Pharm 2009;35:1082–91
   PubMed Web of Science ®Google Scholar
• Dai JG. The preparation of a kind of gambogic acid injection. CHN Patent CN 03131511.9. 2003
   Google Scholar
• Jin B, Dong H, Qiao L. The preparation of a kind of gambogic acid injection. CHN Patent CN 02124510.X. 2003
   Google Scholar
• You QD, Guo QL, Ke X, et al. The preparations of gambogic acid and its compound. CHN Patent CN03132386.3. 2003
   Google Scholar
• Zhao Y, Zhu J, Zhu S, et al. Synthesis and characterization of arginine-modified and europium-doped hydroxyapatite nanoparticle and its cell viability. Trans Nonferrous Met Soc China 2011;21:1773–8
   Web of Science ®Google Scholar
• Noh SM, Park MO, Shim G, et al. Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA. J Control Release 2010;145:159–64
   PubMed Web of Science ®Google Scholar
• Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005;57:559–77
   PubMed Web of Science ®Google Scholar
• Liu C, Pan R, Jiang T, et al. Synthesis and characterization of N-octyl-N-arginine chitosan – a chitosan derivant with a mimetic structure of cell-penetrating peptides. Acta Pharmaceutica Sinica 2012;47:797–802
   PubMedGoogle Scholar
• Huo MR, Zhang Y, Zhou JP, et al. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Inter J Pharm 2010;394:162–73
   PubMed Web of Science ®Google Scholar
• Lv H, Zhang Z, Wang XP, et al. A biomimetic chitosan derivates: preparation, characterization and transdermal enhancement studies of N-arginine chitosan. Molecules 2011;16:6778–90
   PubMed Web of Science ®Google Scholar
• Zhang Z, Abbad S, Pan R, et al. N-octyl-N-arginine chitosan micelles as an oral delivery system of insulin. J Biomed Nanotechnol 2012;9:1–9
   Web of Science ®Google Scholar
• Xiao B, Wan Y, Zhao MQ, et al. Preparation and characterization of antimicrobial chitosan-N-arginine with different degrees of substitution. Carbohydr Polym 2011;83:144–50
   Web of Science ®Google Scholar
• Hao K, Liu XQ, Wang GJ. Pharmacokinetics of gambogic acid in rats. J China Pharm Univ 2005;36:338–45
   Google Scholar
• Hassan EE, Parish RC, Gallo JM. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm Res 1992;9:390–7
   PubMed Web of Science ®Google Scholar
• Li H, Huo M, Zhou J, et al. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. J Pharm Sci 2010;99:4543–53
   PubMed Web of Science ®Google Scholar
• Hou W, Chen B, Zhao Y, Xiao W. Stability of gambogic acid. Chinese Traditional and Herbal Drugs 2011;42:1755–8
   Google Scholar
• Zhai X, Huang L, Song L, et al. Study on the rat intestinal absorption of rapamycin formulated in self-microemulsifying drug delivery system by single-pass intestinal perfusion technique. Chin Hosp Pharm J 2011;31:217–21
   Google Scholar
• Kenichi S, Kouki O, Mayumi Y, et al. High drug loading selfmicroemulsifying/micelle formulation: design by high-throughput formulation screening system and in vivo evaluation. Drug Dev Ind Pharm 2012;38:1254–61
   PubMed Web of Science ®Google Scholar
• Dave RH, Patel AD, Donahue E, Patel HH. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Drug Dev Ind Pharm 2012;38:930–9
   PubMed Web of Science ®Google Scholar
• Crouthame W, Sarapu A. Animal models for oral drug delivery in man. Washington, DC: American Pharmaceutical Association; 1983:27–106
   Google Scholar
• Sutton SC, Rinaldi MT, McCarthy JM, Vukovinsky KE. A statistical method for the determination of absorption rate constant estimated using the rat single pass intestinal perfusion model and multiple linear regression. J Pharm Sci 2002;91:1046–53
   PubMed Web of Science ®Google Scholar
• Berggren S, Hoogstraate J, Fagerholm U, Lennernas H. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models. Eur J Pharm Sci 2004;21:553–60
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeha H, Tajerzadehc H, et al. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharmaceut Sci 2007;10:368–79
   PubMed Web of Science ®Google Scholar
• Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 1996;13:1336–42
   PubMed Web of Science ®Google Scholar
• Gilbert SB. Principles of drug absorption. Pinehurst (NC): Marcel Dekker, Inc. Modern Pharmaceutics: PharmaceuTech, Inc.; 2002:40–62
   Google Scholar
• Gordon LA, Hans L, Vinod PS, John RC. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–20
   PubMed Web of Science ®Google Scholar